We next tested whether IL-22 can confer rotavirus resistance by treating Abx mice with recombinant IL-22 one day before and on days 0, 1, 2 and 4 after oral infection with rotavirus, then monitoring fecal virus shedding by ELISA for the next 12 days. This evidence concerns the gene IL22 and infection.